Evidence map›Paper›PMID 34205977›Full record

ArticleCancers2021

Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas.

Caterina Miro, Annarita Nappi, Annunziata Gaetana Cicatiello, Emery Di Cicco, Serena Sagliocchi, Melania Murolo, Valentina Belli, Teresa Troiani, Sandra Albanese, Sara Amiranda and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Deiodinases in thyroid tumorigenesis.Endocrine-related cancer · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Caterina MiroDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Annarita NappiDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-0876-3323
Annunziata Gaetana CicatielloDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Emery Di CiccoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Serena SagliocchiDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Melania MuroloDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Valentina BelliLaboratorio di Oncologia Molecolare, Dipartimento di Medicina di Precisione, University of Campania Luigi Vanvitelli, 81100 Caserta, Italy.
Teresa TroianiLaboratorio di Oncologia Molecolare, Dipartimento di Medicina di Precisione, University of Campania Luigi Vanvitelli, 81100 Caserta, Italy.
Sandra AlbaneseInstitute of Biostructures and Bioimaging of the National Research Council, 80131 Naples, Italy.
Sara AmirandaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Ann Marie ZavackiHarvard Medical School, Brigham and Women's Hospital, Boston, MA 01451, USA.
Mariano StornaiuoloDepartment of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0003-2200-5083
Marcello ManciniInstitute of Biostructures and Bioimaging of the National Research Council, 80131 Naples, Italy.ORCID 0000-0003-2731-1434
Domenico SalvatoreCEINGE-Biotecnologie Avanzate Scarl, 80131 Naples, Italy.
Monica DenticeDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-9977-3761
University of Naples Federico II · ITCeinge Biotecnologie Avanzate (Italy) · ITInstitute of Biostructure and Bioimaging · ITUniversity of Campania "Luigi Vanvitelli" · ITBrigham and Women's Hospital · US

Funding

PHYSIOLOGY OF THYROID HORMONE-DEPENDENT GENE EXPRESSIONR01DK044128 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI LARSEN, PHILIP REED, ZAVACKI, ANN M · 1992 to 2018
$6.8M
Associazione Italiana per la Ricerca sul Cancro IG 13065European Research Council 639548NIDDK NIH HHS R01 DK044128
6 · The paper itself

Abstract

Cancer angiogenesis is required to support energetic demand and metabolic stress, particularly during conditions of hypoxia. Coupled to neo-vasculogenesis, cancer cells rewire metabolic programs to sustain growth, survival and long-term maintenance. Thyroid hormone (TH) signaling regulates growth and differentiation in a variety of cell types and tissues, thus modulating hyper proliferative processes such as cancer. Herein, we report that TH coordinates a global program of metabolic reprogramming and induces angiogenesis through up-regulation of the

Indexed as

angiogenesisdeiodinasessquamous cell carcinomathyroid hormones

Identifiers

PMID34205977
PMCPMC8199095
OpenAlexW3173095582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.